Ex-Lax Sugar Coated Pills
Natural health product licensed in Canada
- Other names
- Ex-Lax
- Licence holder
- Haleon Canada ULC
- NPN or DIN-HM
- 02226049
- Status
- Active licence
- Licence date
- 31 January 2008
- Revision date
- 16 September 2026
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Cire de Carnauba, Dioxyde de silicium, Poly(alcool vinylique), Povidone, Oxydes de fer, Talc, (p)-hydroxybenzoate de méthyle, Poly(éthylène glycol), Phosphate de calcium, dibasique, dihydraté, Amidon de maïs modifié, Carbonate de calcium, acacia, propylèneglycol, Stéarate de magnésium, Cellulose microcristalline, sulfate sodique de lauryle, Saccharose, Shellac, Benzoate de sodium, (p)-hydroxybenzoate de propyle, Oxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 6 years ; maximum: 11 years | 1 Comprimé | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
| Adultes et enfants | minimum: 12 years | minimum: 1 Comprimé ; maximum: 2 Comprimé | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Relief of occasional constipation
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Do not use daily for more than 1 week without consulting your health care practioner, as overuse or extended use may cause dependence for bowl dunction. Ask a health care practitioner before use if -you have kidney disorder or fecal impaction -you are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications, thiazide diuretics, corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance. When using this product consult a health care practitioner if symptoms persist or worsen. Keep out of reach of children. Stop use and ask a health care practitioner if you experience abdominal pain, cramps, spasms and/or diarrhea.
- Contre-indications
If you are pregnant or breastfeeding in the presence of abdominal pain, nausea, fever or vomiting "if you have abdominal constrictions of the gastrointestinal tract, potential or existing intestinal blockage, atonic bowel, appendicitis, inflammatory bowel disease such as Crohn’s disease or ulcerative colitis, abdominal pain of unknown origin, undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes or diarrhea.
Source
Official Health Canada record, licence 02226049
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.